Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Min-Kyo Jeong"'
Autor:
Su-Been Lee, Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Sang Youn Lee, Mi-Ran Choi, Dong Joon Kim, Ki-Kwang Oh, Ki-Tae Suk
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 52, Iss 1, Pp 250-260 (2024)
Despite many recent studies on non-alcoholic fatty liver disease (NAFLD) therapeutics, the optimal treatment has yet to be determined. In this unfinished project, we combined secondary metabolites (SMs) from the gut microbiota (GM) and Hordeum vulgar
Externí odkaz:
https://doaj.org/article/c274ac6549d04b439968c1996147c160
Autor:
Ki-Kwang Oh, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Byeong-Hyun Min, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Tae Suk
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 51, Iss 1, Pp 217-232 (2023)
AbstractWe comprised metabolites of gut microbiota (GM; endogenous species) and dietary plant-derived natural flavonoids (DPDNFs; exogenous species) were known as potent effectors against non-alcoholic fatty liver disease (NAFLD) via network pharmaco
Externí odkaz:
https://doaj.org/article/f6809733c1a34a9da9af261124cd091f
Autor:
Ki-Kwang Oh, Ickwon Choi, Haripriya Gupta, Ganesan Raja, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Byeong-Hyun Min, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Tae Suk
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 51, Iss 1, Pp 1-12 (2023)
AbstractWe intended to identify favourable metabolite(s) and pharmacological mechanism(s) of gut microbiota (GM) for liver regeneration (LR) through network pharmacology. We utilized the gutMGene database to obtain metabolites of GM, and targets asso
Externí odkaz:
https://doaj.org/article/2d3404a1cc16484c8aa7cc7c5e715b8b
Autor:
Ki-Kwang Oh, Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Tae Suk
Publikováno v:
Cells, Vol 11, Iss 18, p 2903 (2022)
The metabolites produced by the gut microbiota have been reported as crucial agents against obesity; however, their key targets have not been revealed completely in complex microbiome systems. Hence, the aim of this study was to decipher promising pr
Externí odkaz:
https://doaj.org/article/09fe95478f1e43ffb3585599f59069d2
Autor:
Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Yoseph Asmelash Gebru, Satya Priya Sharma, Eunju Park, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A. Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong-Joon Kim, Ki-Tae Suk
Publikováno v:
Biomedicines, Vol 10, Iss 3, p 550 (2022)
Non-alcoholic fatty liver disease (NAFLD) is considered to be a significant health threat globally, and has attracted growing concern in the research field of liver diseases. NAFLD comprises multifarious fatty degenerative disorders in the liver, inc
Externí odkaz:
https://doaj.org/article/754698285e0f46488beaaf303411af5a
Autor:
Min Kyo Jeong, Byeong Hyun Min, Ye Rin Choi, Ji Ye Hyun, Hee Jin Park, Jung A Eom, Sung Min Won, Jin Ju Jeong, Ki Kwang Oh, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Sang Jun Yoon, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk
Publikováno v:
Foods, Vol 11, Iss 17, p 2703 (2022)
Diet and lifestyle are crucial factors that influence the susceptibility of humans to nonalcoholic fatty liver disease (NAFLD). Personalized diet patterns chronically affect the composition and activity of microbiota in the human gut; consequently, n
Externí odkaz:
https://doaj.org/article/4a80b30f9da841c28a7d88bdd3e3271e
Autor:
Sung-Min Won, Ki Kwang Oh, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Jin-Ju Jeong, Sang Jun Yoon, Min Kyo Jeong, Byeong Hyun Min, Ji Ye Hyun, Hee Jin Park, Jung A. Eom, Su Been Lee, Min Gi Cha, Goo Hyun Kwon, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 16, p 8999 (2022)
Hepatic encephalopathy (HE) is a serious complication of cirrhosis that causes neuropsychiatric problems, such as cognitive dysfunction and movement disorders. The link between the microbiota and the host plays a key role in the pathogenesis of HE. T
Externí odkaz:
https://doaj.org/article/c7cb937f71a84f45a14307f7e6fed568
Autor:
Byeong Hyun Min, Devi, Shivani, Goo Hyun Kwon, Gupta, Haripriya, Jin-Ju Jeong, Sharma, Satya Priya, Sung-Min Won, Ki-Kwang Oh, Sang Jun Yoon, Hee Jin Park, Eom, Jung A., Min Kyo Jeong, Ji Ye Hyun, Stalin, Nattan, Tae-Sik Park, Jieun Choi, Do Yup Lee, Sang Hak Han, Dong Joon Kim, Ki Tae Suk
Publikováno v:
Gut Microbes; 2024, Vol. 16 Issue 1, p1-22, 22p
Autor:
Ki-Kwang Oh, Haripriya Gupta, Byeong Hyun Min, Raja Ganesan, Satya Priya Sharma, Sung Min Won, Jin Ju Jeong, Su Been Lee, Min Gi Cha, Goo Hyun Kwon, Min Kyo Jeong, Ji Ye Hyun, Jung A Eom, Hee Jin Park, Sang Jun Yoon, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk
Publikováno v:
Scientific Reports. 13
The metabolites of gut microbiota show favorable therapeutic effects on nonalcoholic fatty liver disease (NAFLD), but the active metabolites and mechanisms against NAFLD have not been documented. The aim of the study was to investigate the active met
Autor:
Ki-Kwang Oh, Ickwon Choi, Haripriya Gupta, Ganesan Raja, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Byeong-Hyun Min, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Tae Suk
Publikováno v:
Artificial cells, nanomedicine, and biotechnology. 51(1)
We intended to identify favourable metabolite(s) and pharmacological mechanism(s) of gut microbiota (GM) for liver regeneration (LR) through network pharmacology. We utilized the gutMGene database to obtain metabolites of GM, and targets associated w